Skip to main content
ABATED

News

Keep up to date with the latest news and updates about the ABATED study

AINOSTICS granted FDA Breakthrough Device Designation
8 September 2022

AINOSTICS has been awarded Breakthrough Device Designation by the US Food and Drug Administration (FDA) to the product, BR[AI]N.

Back to top